Get our guide to planning and executing an M&A communications strategy.Download Now

Westicke Partners

Close

Westwicke Blog

The Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

2020 Gives Rise to Another IPO Alternative: Direct Listings

Posted on October 30th, 2020. Posted by

Wall Street - Direct Listings

In the wake of the coronavirus pandemic, the IPO market may never look the same. The swift shift to virtual roadshows, for example, has demonstrated efficiencies that are likely to make digital alternatives stick even after regular business travel resumes. But beyond the operational changes behind preparing a company to go public, the market has seen growing interest in alternatives to the IPO itself.

Continue Reading

10 Disclosure Guidelines for Clinical Trial Data and Milestones

Posted on October 21st, 2020. Posted by

As life science and medical device companies seek regulatory approval for their products, they will likely encounter difficult disclosure decisions around clinical and regulatory events. Clinical trial data and milestones can present great opportunities as well as significant challenges.

Continue Reading

How to Make the Most of Virtual Non-Deal Roadshows

Posted on October 8th, 2020. Posted by

Virtual Non-Deal Roadshows

The challenges of functioning successfully in an extended COVID-19 environment have presented many new ways of doing business. This is especially evident for events such as non-deal roadshows (NDRs).

Continue Reading

Things to Know About SPAC Transactions

Posted on September 25th, 2020. Posted by

Info About SPAC Transactions

Over the past several months, interest in special purpose acquisition companies (SPACs) has grown exponentially. SPAC transactions serve as an alternative to traditional IPOs, and while they have existed for many years, they are currently experiencing a resurgence within several industries.

Continue Reading

6 Commonly Asked Questions (and Answers) About Quiet Periods

Posted on September 9th, 2020. Posted by

Commonly Asked Questions About Quiet Periods

Public healthcare companies often question the best course of action during quiet periods — those stretches of time during which they should limit their interaction with Wall Street due to their knowledge of material and timely information that has not yet been disclosed. Specifically, management teams struggle to figure out what the quiet period means for their investor relations (IR) efforts.

Continue Reading

The Virtual IPO: How IPOs Are Changing

Posted on August 26th, 2020. Posted by

Expert Advice on IPOs

According to some experts, the past several months have created more change in the IPO market than the last 25 to 30 years. In the recent webinar hosted by ICR Capital and Davis Polk, those experts discussed what they’ve seen in the IPO market recently, changes to standard IPO processes, and what’s to come for IPOs during the remainder of the year.

Continue Reading

Form 8-K vs. Press Release: What’s the Difference?

Posted on August 19th, 2020. Posted by

Form 8-K vs. Press Release

There are many things public companies must consider when disseminating news. What is the most appropriate vehicle to disclose news to investors? In some instances, you will need to file a Form 8-K, the disclosure from the Security and Exchange Commission (SEC). Sometimes, the news will necessitate issuing a press release. And sometimes, you will file both.

Continue Reading

Biotech IPOs: What to Expect in the Second Half of 2020

Posted on August 6th, 2020. Posted by

Biotech IPOs

For much of the first half of 2020, the coronavirus pandemic ground most business to a halt. Biotech innovation, however, has continued in full force. Even during the turbulent first few months of the year, biotech companies have moved forward with successful IPOs.

The pandemic isn’t over, however, and cases continue to rise in parts of the U.S. What will that mean for IPOs in the second half of the year?

Continue Reading

4 Key Questions to Consider When Preparing for Q2 Earnings Season

Posted on July 16th, 2020. Posted by

Questions for Q2 Earnings

The continued uncertainty created by the COVID-19 pandemic will continue to present unique challenges for public company management teams as they report Q2 earnings and attempt to provide the investment community with an appropriate update on the business.

Continue Reading

12 Elements Your Investor Relations Website Must Include

Posted on July 8th, 2020. Posted by

Westwicke Investor Relations Website Checklist

Today, potential investors who are interested in learning about your company will likely visit your website before anything else. To make a good first impression, your investor relations website should be informative, appealing, and easy to navigate. This will allow investors to quickly understand all the fundamentals of your business before setting up a time to meet with management.

Continue Reading

Guidance is a key component of any investor relations program.

Download our checklist of do’s and don’ts for providing effective guidance to investors and analysts. Download Now

Our Locations